Tacrolimus eye drops for severe eye allergy in children
Part of Eyes & vision, Immune system & allergy clinical trials.
This trial tests whether tacrolimus eye drops can reduce the symptoms of vernal keratoconjunctivitis (a severe eye allergy) in children aged 5 to 15. If effective, the treatment could provide a new option to control this uncomfortable condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 5 and 15 years
- Have moderate to severe active vernal keratoconjunctivitis (VKC)
- No other eye infections (besides VKC)
- No contact lens use
- Not taking immunosuppressive medications
- No history of herpes keratitis (a viral eye infection)
- No recent eye surgery or trauma
- No known allergy to the medication tacrolimus
- No other eye diseases like cataracts, glaucoma, or birth defects
- Normal kidney and liver function
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop called diquafosol for people with a severe, active eye allergy called vernal keratoconjunctivitis. It aims to see if the drops can calm the allergy and help heal the surface of the eye.
This trial tests a new eye drop (tacrolimus) to treat non-infectious anterior uveitis, an inflammation in the front part of the eye. It may help reduce the need for steroid eye drops.
This study tests a new eye drop (T1695) against cyclosporine for children with moderate to severe vernal keratoconjunctivitis, a type of eye allergy. It aims to see which treatment works better and is safer for reducing symptoms.
This study tests whether a daily probiotic (a 'good bacteria' supplement) can help reduce symptoms of vernal keratoconjunctivitis (VKC), a type of eye allergy that affects children. It also looks at how the probiotic affects the gut microbiome (the natural bacteria in the gut). If you or your child has VKC and is otherwise healthy, this could be a way to try a natural supplement approach.
This trial tests a new eye drop to reduce itching and other symptoms of allergic conjunctivitis, a condition where the eyes become red, itchy, and uncomfortable due to allergies. It may help people who have not found relief with current treatments.
This trial compares two medicines—oral tacrolimus and dexamethasone micro-pulse therapy—in children aged 4 to 12 whose vitiligo is spreading quickly. The goal is to see which treatment works better to stop the spread and help color return to the skin.
Hear when a new Vernal Keratoconjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.